LRP6 and Alzheimer disease: In a study conducted by Wang et al., it was demonstrated that the activation of Wnt/β-catenin signaling through optogenetic LRP6 stimulation can effectively inhibit and reverse the Aβ-induced BBB damage in both in vitro and animal models of AD [75].